| Donor survey to assess facial flushing during automated red cell collections and medication use. | |
| | |
MedLine Citation:
|
PMID: 21268095 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Background: We conducted a donor survey to assess the occurrence of facial flushing and other symptoms during automated 2-U red cell collections (2RBC) and plateletpheresis (PLT) procedures and evaluated the possible association of the reactions with angiotensin-converting enzyme (ACE) inhibitors or with the collection technology. Methods: An online survey was developed using Zoomerang to capture details of the donors' experience and medication use after 2RBC or PLT donations in regional blood centers of the American Red Cross. Results: Between 12/16/09 and 4/19/10, 1,299 donors in five American Red Cross blood center regions completed an online survey (739 2RBC, 4.2% total registrations; 560 PLT, 2.3% total registrations). Facial flushing was reported by 29 donors, and was more likely associated with 2RBC than PLT procedures (3.0% vs. 1.3%, P = 0.03). Facial flushing with 2RBC donation was reported by eight of 72 (11%) donors on ACE inhibitors; and 14 of 667 (2%) donors who were not taking ACE inhibitors (P = 0.001). The incidence of facial flushing reactions with PLT donation was less than 2% whether donors reported ACEI inhibitor use or not. More than 95% of the donors reported their intent to donate again, regardless of symptoms. Conclusion: Facial flushing was more often reported by 2RBC donors taking ACE inhibitors than other donors [11% vs. 2%; P = 0.001]; and was uncommon among PLT donors, irrespective of ACE inhibitor use (<2%). All blood donors should be informed of the potential for common, minor side effects of the collection procedure and the possible but rare occurrence of more medically serious complications. J. Clin. Apheresis, 2011. © 2011 Wiley-Liss, Inc. |
| | |
Authors:
|
Anne F Eder; Tanya Mitchell; Beth Dy; Ross M Herron; Mary Ellen Wissel; Thomas Lightfoot; Mary Jo Drew; David Mair; |
Related Documents
:
|
16310345 - Assessing the quantitative reliability of solid-state 13c nmr spectra of kerogens acros... 7893305 - Use of a beck airway airflow monitor and controllable-tip endotracheal tube in two case... 21306205 - Sugammadex: a novel approach to reversal of neuromuscular blockade. 19388295 - Controlled lumbar drainage in medically refractory increased intracranial pressure. a s... 6865565 - The administration of medical records in japanese hospitals: a status report. 17877325 - Refuge cover decreases the incidence of bite wounds in laboratory south african clawed ... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-1-25 |
Journal Detail:
|
Title: Journal of clinical apheresis Volume: - ISSN: 1098-1101 ISO Abbreviation: - Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2011-1-26 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8216305 Medline TA: J Clin Apher Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 Wiley-Liss, Inc. |
Affiliation:
|
American Red Cross, Biomedical Services, National Headquarters, Washington, DC. edera@usa.redcross.org. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Positive regulation of inositol 1,4,5-trisphosphate-induced ca(2+) release by mammalian target of ra...
Next Document: Manual color monitoring to optimize hematopoietic progenitor cell collection on the Fenwal Amicus.